UCSF Department of Epidemiology & Biostatistics UCSF School of Medicine UCSF Search UCSF
-
 CTSA KL2
 Overview
 Goal
 Eligibility
 Scholar Selection
 Program Requirements
 Application Advice
 Letter of Intent
 Application
 Review Schedule
 Selection Committee
 Mentors
 Current Scholars
 Public Datasets
 Friday Seminar Schedule


 Other Programs
  Summer Workshop
  Certificate (ATCR)
  Masters
 

CTSA KL2 Scholars Program

Director: Stephen Hulley MD, MPH
Associate Director: Ralph Gonzales MD, MSPH
Assistant Director: Kirsten Bibbins-Domingo MD, PhD, MAS


OVERVIEW

Updated July 21, 2008

The UCSF Clinical and Translational Science Institute Career Development Program (CTSA KL2) is supported by the UCSF Clinical and Translational Sciences Institute (CTSI). This year 4-5 Scholars at the faculty level will be selected for a career development award to begin July 1, 2009. Scholars will receive 4-5 years (depending on level of training upon entering the program) of salary support at $75,000 per year to pursue multidisciplinary clinical research with training and mentoring. Clinical research is defined broadly as everything but pure bench science, and the program emphasizes T1 translational research (basic science to clinical application studies) and T2 translational research (clinical application to improved health in the population). The program includes a master's degree in clinical research for those who do not have such training, a supportive environment, start-up research funds, weekly work-in-progress and methodology seminars, and access to core faculty who provide expertise and guidance in research design, measurement and questionnaire design, study coordination, data management, biostatistical analysis, publishing and presenting research, and manuscript and grant writing.

In addition to the CTSI KL2 career development award, CTSI also provides clinical and translational research training and mentored support to individuals at UCSF who have K-type career development awards. The expectations and instructions for applying to the CTSI K Scholars program are described below.

GOAL

The goal is to increase the number and quality of outstanding clinical investigators skilled at leading multidisciplinary research teams. The overarching goal is to promote clinical and translational investigation that will have an important impact on the health of the public.

ELIGIBILITY
Candidates for CTSI KL2 awards must:
  • Be a U.S. Citizen or Permanent Resident; individuals on temporary or student visas are not eligible
  • Possess a doctoral-level degree (MD, PhD, Pharm D, DDS, etc.) and be a junior (first several years) faculty member
  • Commit 75% of professional effort to the program
  • Not be or have been a principal investigator on an NIH R01, or project leader on a subproject of a Program Project (P01), Center (P50, P60, U54), mentored career development grant (K23, K08, K01, etc.), or equivalent non-PHS peer reviewed research grants that are over $100,000 in direct costs per year. May have had support on a NRSA grant (F or T) or NIH small grant (R03 or R21). (Note: Candidates may have had previous support on a K-12 award, but the CTSI KL2 cannot extend total K support beyond 5 years.)
SCHOLAR SELECTION CRITERIA

A campus-wide Selection Committee will review the scholar applications following the model of the NIH peer review process. Selection criteria will focus on the strengths and potential of the candidate to become a leading multidisciplinary clinical investigator judged in five major domains:

    1. Track Record: Creativity of the candidate and potential to lead excellent multidisciplinary research judging by track record in some or all of the following: areas of expertise and prior training; publications; funded grants; written product attached to the application

    2. Research Plan: Scientific value, potential clinical importance, and feasibility of the written multidisciplinary research plan

    3. Training Plan: Quality, appropriateness, and multidisciplinary complementarity of the proposed mentors, and plan for additional didactic and other training at UCSF or elsewhere

    4. Resources: Tangible commitment and resources provided by the home department/ORU, and suitability of the available clinical and laboratory infrastructure and multidisciplinary team

    5. Career Potential: Global assessment of the likelihood that the candidate will develop a career as an outstanding investigator who will lead multidisciplinary teams and have an important impact on health

Individuals from underrepresented ethnic minority groups are encouraged to apply, and special consideration will be given to individuals in departments and disciplines that have traditionally been under-represented in clinical research.

PROGRAM REQUIREMENTS

  1. Duration of the Award

CTSI KL2 Scholars who enter the program with at least one year of advanced training in clinical research (Advanced Training in Clinical Research (ATCR) Certificate or MAS Degree from UCSF, or equivalent) will receive 4 years of salary support at $75,000 per year. Scholars who have not had advanced training in clinical research will obtain the Master's degree (or under some circumstances the ATCR Certificate) as a KL2 Scholar and will receive 5 years of salary support at $75,000 per year. Each year of funding is contingent on satisfactory participation in the CTSI KL2 activities and progress toward the scholar's individual career goals, and continued support from the Scholar's mentors and department. These expectations must be qualified by the fact that competitive renewal of our funding as part of the CTSI is anticipated in July 2011, and whereas it is unlikely that there will be an interruption of our funding, we cannot guarantee it.

  1. Professional Effort Devoted to the Program

Generally, 75% of a Scholar's full-time professional effort must be devoted to the KL2 program for the training and clinical research activities. The 75% effort is based on the entire amount of time worked in a typical week, and should include proportionate amounts of normal weekday time. The remaining 25% effort can be divided among other research, clinical and teaching activities if these activities are consistent with the proposed goals of the KL2 program.

  1. Didactic Training in Clinical and Translational Research

The requirement will normally be met by enrolling in our 2-year Master of Advanced Studies in Clinical Research Degree, or equivalent. Under some circumstances, such as when the Scholar already has an MPH, the 1-year ATCR Certificate program may be a suitable alternative. Scholars who already have two years of advanced training in clinical research may take individual courses to complete gaps in or update previous training. Those who have not taken our cornerstone Designing Clinical Research course (Epi 202) will find it an excellent and relevant review.

In addition to taking TICR courses as noted above, we strongly recommend that all Scholars enroll in other courses and workshops in disciplines relevant to their career development plans at UCSF and at other institutions; these should be planned in discussions with mentors and CTSA KL2 advisors. Within broad limits tuition, whether at UCSF or elsewhere, is paid for by the program.

Individuals who are selected as CTSI KL2 Scholars and who will obtain a Master's degree as part of their training plan must complete a separate application for a Master's Degree in Clinical Research that is due by April 6, 2009. Information and application materials are available on the Master's Program website.

  1. Mentors

Developing a successful clinical research career requires strong relationships with mentors and a research team. Each Scholar must have a lead mentor and at least one other mentor from a different discipline. Mentors should have sufficient independent research support to cover the costs of the proposed research project in excess of the allowable costs of the KL2.

Lead mentors will have overall responsibility for helping Scholars develop creative and independent careers in research. In addition to being an expert in the scientific area the Scholar has chosen to pursue, a lead mentor must be familiar with faculty, resources and databases at UCSF, and have resources and research staff that can support the Scholars' research. Lead mentors will provide guidance to the Scholar to assure that projects are moving satisfactorily on the path to presentations, publications, and grant applications, and they will provide advice about career directions, national networking, and academic promotion. They will also help to assure that 75% of the Scholar's total work week is protected from clinical and administrative duties, and fully available for training and research. Co-mentors will be responsible for working with the lead mentor on these responsibilities, and will provide guidance in one or more complementary areas of expertise.

Scholars will meet frequently with the lead mentor, both individually and in conjunction with other members of the research team. Scholars will also meet regularly with their co-mentors, and at least twice a year with all their mentors as a group. Mentors are encouraged to participate in at least one of the Scholar's Work-in-Progress seminars each year, and to work with the scholar on a Career Development Plan due in August and updated in January and August each year. Mentors are also required to meet with the CTSI KL2 principal advisor of the scholar, and to participate in efforts to evaluate and improve mentoring at UCSF. Each scholar is also expected to meet periodically with her/his division head/department chair who will oversee the scholar's departmental interactions and academic advancement.

Selection Committee members may also serve as mentors but during the selection of the candidate, these individuals will be excused from the discussion and vote.

  1. Clinical Research Facility

Each scholar will be provided space and a computer at the Department of Epidemiology and Biostatistics Clinical Research Facility at 185 Berry St, China Basin Landing, San Francisco. Scholars may occupy a "hotel" cubicle or office for the days they wish to work at the facility. Having attractive and functional space and dedicated personnel for the Scholars embedded in a much larger set of clinical research activities and support technologies is an important strength of the CTSI KL2 Program, one that will optimize the scholars' acquisition of skills in research methodology and ability to build and lead interdisciplinary teams. Most scholars will also have an office, computer and administrative support at the site of their clinical research in their department.

In addition to space for the Scholars, the Clinical Research Facility includes the offices of the core faculty (John Boscardin, David Glidden, Amy Markowitz, Charles McCulloch, Tom Mitchell, John Neuhaus, Tom Novotny, Dennis Osmond, Eric Vittinghoff, and Louise Walter) and the offices of the Director (Steve Hulley), the Associate Director (Ralph Gonzales), the Assistant Director (Kirsten Bibbins-Domingo), the Deputy Director (Chris Ireland), the Finance and Technology Coordinator (Shirley Yuen), the Program Assistant (Allison Deneen), the TICR Program Director (Jeff Martin), and other relevant staff.

We consider the time spent in physical proximity to each other and to clinical research expertise to be extremely important for forming a support group during a Scholar's first 1-2 years in the program. For this reason, scholars are encouraged to spend as much time as possible at the clinical research facility and will be required to spend at least one morning per week in residence, on Fridays. Core faculty will also be in residence on Fridays to make it easy for scholars to informally discuss issues regarding their research with faculty or arrange meetings if desired.

  1. Attendance at Seminars, Annual Retreat, Core Courses, Other Activities

CTSI KL2 Scholars are required to attend weekly work-in-progress seminars held on Friday mornings at our China Basin facility. The seminars serve as the glue of the program, an opportunity for scholars to meet regularly, review and contribute to each other's work and obtain expert methodologic advice, as well as be exposed to high quality clinical researchers from a variety of disciplines who will lead guest lectures throughout the year. These seminars will address a variety of topics, in keeping with our multidisciplinary mission, but will focus on methodologic issues as the unifying theme. Each scholar is expected to lead 4-6 work-in-progress discussions each year during their first 2 years, and in later years to lead methodologic seminars.

In July, there will be a retreat to kick off the program and provide the opportunity for old and new scholars to get to know the program faculty and staff, and each other.

In addition, there may be special activities scheduled throughout the year such as career development forums and opportunities to observe IRB proceedings. Scholars are also asked to participate as teachers and mentors in the training and career development of pre- and post-doctoral students. These activities are in addition to the coursework required by the Master's Degree in Clinical Research.

  1. Supporting CTSI Programs

Scholars are expected to contribute to the goals of the CTSI in the UCSF Pathways Program. This includes serving as role models for pre-doctoral PACCTR and Doris Duke fellows and for clinical fellows, and teaching clinical and translational science methods to others in the K Program and in other UCSF populations. As part of this, scholars are expected to participate at least once during their tenure in the CTSI K Program as an instructor in a TICR course (for example, leading a section in Designing Clinical Research). This expectation is designed in part to enable the Program to respond to the growing need for what we teach, and in part to add a relevant element to the career development of scholars. There is no better way to enhance expertise in the methods of clinical and translational science than to teach them.

  1. Attendance at annual CTSA KL2 meeting

Scholars are required to attend the national annual meeting (or a mutually agreed alternative) for clinical research scholars and program directors paid for by the scholars' KL2 travel funds, which provides an opportunity for the scholars to meet their Scholar colleagues from across the nation and present their work. These meetings will usually take place in Washington, D.C. in late March.

  1. Scholar career development plans, progress reports, and performance feedback

Scholar Milestones

Since our shared goal is for scholars to become independently funded by the end of their K award period (or earlier), we set out these general guidelines for scholars to consider:


By the end of the 2nd year, and each year thereafter:

  • 3 original research multidisciplinary peer-reviewed publications submitted, two of these as first or last author
  • One multidisciplinary extramural grant of any size submitted (typically R21, R03, or other federal, state, foundation, industry, or intramural grant).

By the middle of the 3rd Year (or end of the 3rd year for scholars taking ATCR, Masters, other full time course work in the first year):

  • One multidisciplinary, R01 grant (or equivalent) submitted.

Scholar Performance Reviews

August

  • Scholars, in consultation with their mentors, create or update a "career development plan" for review by their "KL2 Advisor" (the CTSA KL2 Director or his designee).

January

  • Scholars update their career development plan for review with their mentors and with their KL2 Advisor. The mentors also meet with the KL2 Advisor in person or by telephone, and these assessments are reviewed at a KL2 faculty meeting. The meetings are the main opportunity to identify actions the scholar needs to take to assure continuation in the program the following July.

March

  • Scholars complete an annual NIH progress report.

APPLICATION ADVICE

We recommend that individuals interested in learning about how to write successful research or career development award applications attend the Grantwriting Workshop offered free this Fall and led by Tom Mitchell, our resident expert.

LETTER OF INTENT

Candidates must submit a letter of intent and a CV formatted following UCSF guidelines by November 17, 2008. Based on the letter, candidates will either be invited to submit full applications or advised not to apply for this award this year. Our goal is to provide this response by December 8, 2008.

The Letter of Intent is an online application. Upon submitting your completed letter of intent, please e-mail your CV to Allison Deneen (adeneen@psg.ucsf.edu). For your letter of intent to be considered complete, we must receive your online application and your CV by noon on November 17, 2008.

 

APPLICATION

Candidates must complete the application following the instructions included in the application packet. Applications are due by noon on February 2, 2009.

The application instructions and format are included below. To use this, click on the button below. The word document should then appear in your browser. Next select "File > Save As" from the menu bar and save a local copy of the document to your computer. Use this version of the document for your responses. Please contact Allison Deneen if you experience any problems using this application form or have any questions.

Completed, signed (electronic signatures are acceptable if sent from your computer) applications must be submitted by email to Allison Deneen (adeneen@psg.ucsf.edu) by noon on February 2, 2009.

RECEIPT, REVIEW, AWARD SCHEDULE

Call for Applications August 2008
Letter of intent due November 17, 2008
Response to letter of intent December 8, 2008
KL2 Applications due February 2, 2009
Applicant Interviews February 10-27, 2009
Initial notification of awards March 30, 2009
Master's Applications due April 6, 2009
Submit scholar appointment forms to NIH May 31, 2009
Appointment start date July 1, 2009